Cargando…

Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia

In this study, we attempted to assess the interactions of resveratrol, a natural compound present in various plant species, with the purine analogues fludarabine and cladribine in terms of their effects on DNA damage and apoptosis in chronic lymphocytic leukemia (CLL) cells. The experiments were per...

Descripción completa

Detalles Bibliográficos
Autores principales: Podhorecka, Monika, Halicka, Dorota, Klimek, Piotr, Kowal, Malgorzata, Chocholska, Sylwia, Dmoszynska, Anna
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018253/
https://www.ncbi.nlm.nih.gov/pubmed/20714724
http://dx.doi.org/10.1007/s00277-010-1045-7
_version_ 1782196040766586880
author Podhorecka, Monika
Halicka, Dorota
Klimek, Piotr
Kowal, Malgorzata
Chocholska, Sylwia
Dmoszynska, Anna
author_facet Podhorecka, Monika
Halicka, Dorota
Klimek, Piotr
Kowal, Malgorzata
Chocholska, Sylwia
Dmoszynska, Anna
author_sort Podhorecka, Monika
collection PubMed
description In this study, we attempted to assess the interactions of resveratrol, a natural compound present in various plant species, with the purine analogues fludarabine and cladribine in terms of their effects on DNA damage and apoptosis in chronic lymphocytic leukemia (CLL) cells. The experiments were performed ex vivo using short-term cell cultures of blood and bone marrow cells from newly diagnosed untreated patients. We analyzed the expression of active caspase-3 and the BCL-2/BAX ratio as markers of apoptosis and the expression of phosphorylated histone H2AX (γH2AX) and activated ATM kinase, which are reporters of DNA damage. The results of our study revealed that resveratrol induced apoptosis in CLL cells in a tumor-specific manner but did not affect non-leukemic cells, and apoptosis was associated with a decreased BCL2/BAX ratio. Here, we report for the first time that both resveratrol + fludarabine and resveratrol + cladribine caused a higher rate of apoptosis in comparison to the rate caused by a single drug. The percentage of apoptotic cells induced by resveratrol alone was higher in the group of patients with better prognostic markers than in those with worse prognostic markers. However, the rates of apoptosis caused by resveratrol combined with purine analogues were independent of ZAP-70 and CD38 expression and the clinical state of the disease; they were only dependent on the presence of high-risk cytogenetic abnormalities. We also observed an increase in γH2AX expression together with a rise in activated ATM in most of the analyzed samples. The obtained results indicate that resveratrol might warrant further study as a new therapeutic option for CLL patients. This naturally occurring substance may be used as a single agent, especially in older persons for whom there are some limitations for the use of aggressive treatment. On the other hand, a lower purine analogue dose could potentially be used in combination with resveratrol because of their combined effect. One of the mechanisms of action of resveratrol is the induction of DNA damage, which ultimately leads to apoptosis.
format Text
id pubmed-3018253
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-30182532011-02-04 Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia Podhorecka, Monika Halicka, Dorota Klimek, Piotr Kowal, Malgorzata Chocholska, Sylwia Dmoszynska, Anna Ann Hematol Original Article In this study, we attempted to assess the interactions of resveratrol, a natural compound present in various plant species, with the purine analogues fludarabine and cladribine in terms of their effects on DNA damage and apoptosis in chronic lymphocytic leukemia (CLL) cells. The experiments were performed ex vivo using short-term cell cultures of blood and bone marrow cells from newly diagnosed untreated patients. We analyzed the expression of active caspase-3 and the BCL-2/BAX ratio as markers of apoptosis and the expression of phosphorylated histone H2AX (γH2AX) and activated ATM kinase, which are reporters of DNA damage. The results of our study revealed that resveratrol induced apoptosis in CLL cells in a tumor-specific manner but did not affect non-leukemic cells, and apoptosis was associated with a decreased BCL2/BAX ratio. Here, we report for the first time that both resveratrol + fludarabine and resveratrol + cladribine caused a higher rate of apoptosis in comparison to the rate caused by a single drug. The percentage of apoptotic cells induced by resveratrol alone was higher in the group of patients with better prognostic markers than in those with worse prognostic markers. However, the rates of apoptosis caused by resveratrol combined with purine analogues were independent of ZAP-70 and CD38 expression and the clinical state of the disease; they were only dependent on the presence of high-risk cytogenetic abnormalities. We also observed an increase in γH2AX expression together with a rise in activated ATM in most of the analyzed samples. The obtained results indicate that resveratrol might warrant further study as a new therapeutic option for CLL patients. This naturally occurring substance may be used as a single agent, especially in older persons for whom there are some limitations for the use of aggressive treatment. On the other hand, a lower purine analogue dose could potentially be used in combination with resveratrol because of their combined effect. One of the mechanisms of action of resveratrol is the induction of DNA damage, which ultimately leads to apoptosis. Springer-Verlag 2010-08-17 2011 /pmc/articles/PMC3018253/ /pubmed/20714724 http://dx.doi.org/10.1007/s00277-010-1045-7 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Article
Podhorecka, Monika
Halicka, Dorota
Klimek, Piotr
Kowal, Malgorzata
Chocholska, Sylwia
Dmoszynska, Anna
Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia
title Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia
title_full Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia
title_fullStr Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia
title_full_unstemmed Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia
title_short Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia
title_sort resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018253/
https://www.ncbi.nlm.nih.gov/pubmed/20714724
http://dx.doi.org/10.1007/s00277-010-1045-7
work_keys_str_mv AT podhoreckamonika resveratrolincreasesrateofapoptosiscausedbypurineanaloguesinmalignantlymphocytesofchroniclymphocyticleukemia
AT halickadorota resveratrolincreasesrateofapoptosiscausedbypurineanaloguesinmalignantlymphocytesofchroniclymphocyticleukemia
AT klimekpiotr resveratrolincreasesrateofapoptosiscausedbypurineanaloguesinmalignantlymphocytesofchroniclymphocyticleukemia
AT kowalmalgorzata resveratrolincreasesrateofapoptosiscausedbypurineanaloguesinmalignantlymphocytesofchroniclymphocyticleukemia
AT chocholskasylwia resveratrolincreasesrateofapoptosiscausedbypurineanaloguesinmalignantlymphocytesofchroniclymphocyticleukemia
AT dmoszynskaanna resveratrolincreasesrateofapoptosiscausedbypurineanaloguesinmalignantlymphocytesofchroniclymphocyticleukemia